Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
39.60
-0.10 (-0.25%)
May 20, 2026, 5:24 PM IDT
Market Cap463.75M +140.6%
Revenue (ttm)n/a
Net Income-24.49M
EPS-0.02
Shares Out1.17B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume758,786
Average Volume936,292
Open39.20
Previous Close39.70
Day's Range38.60 - 40.80
52-Week Range19.30 - 60.90
Beta0.86
RSI43.12
Earnings DateApr 13, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases. Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue gra... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 42
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements